Congresses
The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Leslie Citrome, MD, MPH1 ; Christoph U. Correll, MD2-4; Gregory W. Mattingly, MD5 ; Andrew J. Cutler, MD6 ; Amber R. Hoberg, NP, CRNP7 ; Peter J. Weiden, MD8 ; Bhaskar Rege, PhD9 ; James A. McGrory, PhD9 ; Martin Dunbar, PhD9 ; Craig Hopkinson, MD9 ; David McDonnell, MD10
1 New York Medical College, Valhalla, NY, USA; 2 Zucker Hillside Hospital, Glen Oaks, NY, USA; 3 Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; 4 Charité Universitätsmedizin, Berlin, Germany; 5 St. Charles Psychiatric Associates, St. Charles, MO, USA; 6 SUNY Upstate Medical University Hospital, Syracuse, NY, USA; 7 WellMed Medical Management, South Texas Medical Center, San Antonio, TX, USA; 8 Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, USA; 9 Alkermes, Inc., Waltham, MA, USA; 10Alkermes Pharma Ireland Ltd, Dublin, Ireland
